T-cell immunotherapy with a chimeric receptor against CD38 is effective in eliminating myeloma cells

K. Mihara, J. Bhattacharyya, A. Kitanaka, K. Yanagihara, T. Kubo, Y. Takei, H. Asaoku, Y. Takihara, A. Kimura

Research output: Contribution to journalLetter

47 Citations (Scopus)
Original languageEnglish
Pages (from-to)365-367
Number of pages3
JournalLeukemia
Volume26
Issue number2
DOIs
Publication statusPublished - 02-2012

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Mihara, K., Bhattacharyya, J., Kitanaka, A., Yanagihara, K., Kubo, T., Takei, Y., Asaoku, H., Takihara, Y., & Kimura, A. (2012). T-cell immunotherapy with a chimeric receptor against CD38 is effective in eliminating myeloma cells. Leukemia, 26(2), 365-367. https://doi.org/10.1038/leu.2011.205